Full-Time

Specialist

Training & Documentation

Posted on 8/27/2024

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

51-200 employees

Develops RNAi-based therapies for diseases

Biotechnology
Healthcare

Compensation Overview

$70k - $82kAnnually

Mid

No H1B Sponsorship

Fitchburg, WI, USA

Category
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Google Cloud Platform
Requirements
  • Minimum of an Associate degree in applicable science field
  • Working knowledge of GMP, GCP, and/or GLP regulations
  • Competent knowledge of, and ability to use and format within Adobe Acrobat and Microsoft Office
Responsibilities
  • Manage employee’s training files and job descriptions within Arrowhead’s EDMS
  • Issue controlled forms, notebooks, etc
  • Assist with preparation, update, review, and routing of Arrowhead procedural documents
  • Assist QA management with the implementation and upkeep of a LMS (Learning Management System), including development and management of training curricula, driving consistency across departments, and ensuring access to proper leaning materials
  • Track and report on training compliance; notify management of over-due employee training requirements
  • Interact with personnel companywide to obtain the necessary information and details for preparing training records
  • Upload documents to Arrowhead’s EDMS, Veeva QualityDocs, and route for electronic approval
  • Scan and upload executed documents to the EDMS, properly categorize within the system, and route for verification/approval
  • Manage and ensure timely review of periodic review assignment within the EDMS
  • Write standard operating procedures and work instructions as needed for all types of quality systems and practices
  • Assist with Veeva and other system implementations
  • Assist with QA duties as needed
Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

View

Arrowhead Pharmaceuticals develops medicines aimed at treating severe diseases by targeting and silencing specific genes. The company uses RNA interference (RNAi), a natural process that reduces gene expression, to create therapies that can potentially stop or reverse diseases like cystic fibrosis and hepatitis B. Their approach involves a variety of RNA chemistries and effective delivery methods to ensure that the target genes are significantly reduced in activity. Unlike many competitors, Arrowhead focuses specifically on RNAi-based therapies, which allows them to address medical needs that are not met by existing treatments. The goal of Arrowhead Pharmaceuticals is to provide new treatment options for patients suffering from genetic disorders, leveraging their expertise and partnerships to bring these therapies to market.

Company Stage

IPO

Total Funding

$4.7M

Headquarters

Pasadena, California

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Arrowhead's collaboration with Sarepta Therapeutics brings significant financial and research opportunities.
  • The new obesity program could offer a gentler alternative to existing treatments.
  • Phase 2 data for plozasiran shows promising results for severe hypertriglyceridemia treatment.

What critics are saying

  • Regulatory approval is uncertain for RNAi-based therapies, impacting market entry timelines.
  • Dependence on partnerships may affect revenue stability if collaborations falter.
  • The competitive biotech landscape poses challenges for Arrowhead's market positioning.

What makes Arrowhead Pharmaceuticals unique

  • Arrowhead uses RNAi technology for gene silencing, targeting severe genetic diseases.
  • The company has a broad portfolio of RNA chemistries for efficient gene knockdown.
  • Arrowhead's strategic partnerships enhance its drug discovery and development capabilities.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE